Cargando…
Von Willebrand factor propeptide as a marker of disease activity in systemic sclerosis (scleroderma)
In 44 consecutive patients with systemic sclerosis (SSc), plasma concentrations of von Willebrand factor (vWf) were higher than those of the vWf propeptide, but the propeptide showed less variability within patient subgroups. Higher values of the propeptide were observed in patients with early pulmo...
Autores principales: | Scheja, Agneta, Åkesson, Anita, Geborek, Pierre, Wildt, Marie, Wollheim, Claes B, Wollheim, Frank A, Vischer, Ulrich M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC30710/ https://www.ncbi.nlm.nih.gov/pubmed/11299058 |
Ejemplares similares
-
Serum IL-15 in patients with early systemic sclerosis: a potential novel marker of lung disease
por: Wuttge, Dirk M, et al.
Publicado: (2007) -
The Use of Phage Display and Yeast Based Expression System for the Development of a Von Willebrand Factor Propeptide Assay: Development of a Von Willebrand Factor Propeptide Assay
por: Meiring, S. M., et al.
Publicado: (2018) -
Elevated Plasma Von Willebrand Factor and Propeptide Levels in Malawian Children with Malaria
por: Phiri, Happy T., et al.
Publicado: (2011) -
Von Willebrand factor propeptide and pathophysiological mechanisms in European and Iranian patients with type 3 von Willebrand disease enrolled in the 3WINTERS‐IPS study
por: Pagliari, Maria Teresa, et al.
Publicado: (2022) -
Plasma Level of von Willebrand Factor Propeptide at Diagnosis: A Marker of Subsequent Renal Dysfunction in Autoimmune Rheumatic Diseases
por: Yada, Noritaka, et al.
Publicado: (2020)